TY  - JOUR
AU  - Rodelo-Haad, Cristian
AU  - Rodriguez-Ortiz, Maria E
AU  - Martin-Malo, Alejandro
AU  - Pendon-Ruiz de Mier, M Victoria
AU  - Agüera, M Luisa
AU  - Muñoz-Castañeda, Juan R
AU  - Soriano, Sagrario
AU  - Caravaca, Francisco
AU  - Alvarez-Lara, M Antonia
AU  - Felsenfeld, Arnold
AU  - Aljama, Pedro
AU  - Rodriguez, Mariano
PY  - 2018
DO  - 10.1371/journal.pone.0201537
UR  - http://hdl.handle.net/10668/12812
T2  - PloS one
AB  - In hemodialysis patients, high levels of Fibroblast Growth Factor 23 (FGF23) predict mortality. Our study was designed to test whether the control of serum phosphate is associated with a reduction in serum FGF23 levels. Additionally other variables...
LA  - en
PB  - Public Library of Science
KW  - Aged
KW  - Aged, 80 and over
KW  - C-reactive protein
KW  - Calcium
KW  - Chelating agents
KW  - Cross-sectional studies
KW  - Female
KW  - Fibroblast growth factor-23
KW  - Fibroblast growth factors
KW  - Humans
KW  - Hyperphosphatemia
KW  - Longitudinal studies
KW  - Male
KW  - Middle aged
KW  - Phosphates
KW  - Prospective studies
KW  - Renal dialysis
KW  - Renal insufficiency, chronic
KW  - Survival analysis
KW  - Treatment outcome
TI  - Phosphate control in reducing FGF23 levels in hemodialysis patients.
TY  - Research article
VL  - 13
ER  -